- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Platinum Resistant
Total 5512 results
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomaUnited States
-
Southern Europe New Drug OrganizationClinical Trial Unit Ente Ospedaliero CantonaleCompletedAdvanced Head and Neck Squamous Cancer
-
Northwestern UniversityNational Comprehensive Cancer NetworkCompletedRecurrent Fallopian Tube Cancer | Recurrent Epithelial Ovarian Cancer | Recurrent Primary Peritoneal CancerUnited States
-
EndocyteTerminated
-
MaxCyte, Inc.CTI Clinical Trial and Consulting ServicesTerminatedFallopian Tube Adenocarcinoma | Peritoneal Mesothelioma | Primary Peritoneal Carcinoma | Adenocarcinoma of the OvaryUnited States
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Unknown
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
PsiOxus Therapeutics LtdCompletedRecurrent Platinum Resistant Ovarian CancerUnited Kingdom, Spain
-
University Health Network, TorontoCompletedPlatinum-resistant Epithelial Ovarian CancerCanada
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
National Institute of Allergy and Infectious Diseases...CompletedAlphavirus Infections | Eastern Equine Encephalitis | Venezuelan Equine Encephalitis | Western Equine EncephalitisUnited States
-
Peking Union Medical College HospitalUnknownRecurrent Platinum-resistant Ovarian CancerChina
-
Masonic Cancer Center, University of MinnesotaCompletedIntraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal IntFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
NuCana plcTerminatedOvarian CancerUnited States, United Kingdom
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Greece, Canada, Finland, Italy, Spain, United Kingdom, France, Denmark, South Africa, Australia, Poland
-
Sun Yat-sen UniversityCompleted
-
Vejle HospitalCompletedOvarian CancerDenmark
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedOvarian CancerBelgium, United States, United Kingdom
-
Xiaoxiang ChenUnknownNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditionsChina
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
OncoMed Pharmaceuticals, Inc.TerminatedPrimary Peritoneal CarcinomaUnited States
-
First Affiliated Hospital of Harbin Medical UniversityTerminated
-
Duke UniversityCompletedPalliative Care | Platinum-resistant Ovarian Cancer | Recurrent Ovarian CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedPlatinum Resistant Ovarian CancerUnited States
-
PharmaMarCompletedOvarian CancerUnited States
-
Seoul National University HospitalUnknownHigh Grade Serous Carcinoma | Ovarian Neoplasm EpithelialKorea, Republic of
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)WithdrawnOvarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
-
BayerCompletedOvarian NeoplasmsBelgium, Spain, Moldova, Republic of, United States
-
Hospices Civils de LyonUnknownOvarian Epithelial CancerFrance
-
DelMar Pharmaceuticals, Inc.WithdrawnOvarian CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
NYU Langone HealthGenentech, Inc.; University of New Mexico Cancer CenterCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAdenocarcinoma | Gastric CancerUnited States, Canada, Brazil, Czechia, Egypt, Korea, Republic of, Lebanon, Poland, Russian Federation, Spain, Romania, United Kingdom, Australia, Croatia, Italy, Philippines, Thailand, Argentina, Bosnia and Herzegovina, Chile, ... and more
-
Carilion ClinicGlaxoSmithKlineWithdrawn
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Blokhin's Russian Cancer Research CenterUnknownOvarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous AdenocarcinomaRussian Federation
-
Royal Marsden NHS Foundation TrustUniversity College London (UCL) Cancer InstituteUnknownTesticular Germ Cell TumorUnited Kingdom
-
Henan Cancer HospitalUnknown
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedBreast Cancer | DermatitisUnited States
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
Aduro Biotech, Inc.Incyte CorporationTerminatedPlatinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal CancerUnited States, Canada
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance
-
AGC Biologics S.p.A.Completed